Scientific References
The following scientific studies and publications support the health claims and formulations used in our products.
Liposomal-encapsulated Ascorbic Acid: Influence on Vitamin C Bioavailability and Capacity to Protect Against Ischemia–Reperfusion Injury*
-
2016 Jun 20;9:25–30.
Auth Janelle L Davis et al
The above study demonstrated that oral delivery of vitamin C encapsulated in liposomes (1) produced circulating concentrations of vitamin C greater than those elicited by oral delivery of unencapsulated vitamin C and (2) provided protection from ischemia–reperfusion that was similar to the protection provided by oral unencapsulated vitamin C and intravenous vitamin C administration.
https://pmc.ncbi.nlm.nih.gov/articles/PMC4915787/
Bioavailability by design - Vitamin D3 liposomal delivery vehicles
Liposomal encapsulation of cholecalciferol mitigates in vivo toxicity and delays tumor growth
2025 Jan 27;16:1529007.
Miriam Ezcurra-Hualde et al.
Summary : Liposomal encapsulation of vitamin D3 significantly improves its anticancer efficacy while mitigating toxicity, making it a promising strategy for future cancer therapies. VD-LP shows potential for enhanced therapeutic applications with reduced adverse effects, warranting further clinical exploration. The findings suggest that liposomal encapsulation not only enhances the delivery and efficacy of vitamin D3 but also significantly reduces the risk of hypercalcemia and other toxic effects, thus offering a safer alternative for clinical use.
https://pmc.ncbi.nlm.nih.gov/articles/PMC11807986/